Atlas Trials

Breast Cancer RElapsed in Patients Treated With Adjuvant CDK4/6 Inhibitors:

Clinical trial NCT07180693 · RECRUITING

Trial details

NCT number
NCT07180693
Sponsor
European Institute of Oncology
Status
RECRUITING
Study type
OBSERVATIONAL
Adjuvant TherapyCDK4/6 Inhibitor
Start date
2025-09-29
Primary completion
2028-08-01
Enrollment
750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.